Wednesday, December 11, 2024
HomeCorporate actionIPOsSuraksha Diagnostic IPO Debut In The Market: Check Status, GMP & More!

Suraksha Diagnostic IPO Debut In The Market: Check Status, GMP & More!

Suraksha Diagnostic: Today, Suraksha Diagnostic Ltd.’s equity shares are scheduled to debut on the stock exchange. During its subscription period, Suraksha Diagnostic Ltd.’s initial public offering (IPO) garnered a respectable response. Today, December 6 is the date of Suraksha Diagnostic’s initial public offering. 

“With effect from Friday, December 6, 2024, trading members of the Exchange are hereby informed that the equity shares of SURAKSHA DIAGNOSTIC LIMITED shall be listed and admitted to dealings on the Exchange in the list of B’ Group of Securities,” a notification posted on the BSE stated.

GMP for Suraksha Diagnostic IPO: 

The gray market is now seeing a weak trend for Suraksha Diagnostic shares. Stock market watchers report that the Suraksha Diagnostic IPO GMP is ₹13 per share today before listing. This shows that the market shares of Suraksha Diagnostic are trading on the gray market for ₹13 more than their issue price.

Listing Price for Suraksha Diagnostic IPO:

The expected listing price of Suraksha Diagnostic shares, taking into account the Suraksha Diagnostic IPO GMP today, would be ₹454 per share, which is almost 3% more than the IPO price of ₹441 per share.

Suraksha Diagnostic IPO Details:

The Suraksha Diagnostic IPO closed on Tuesday, December 3, after opening for subscriptions on Friday, November 29. The Suraksha Diagnostic IPO listing date is today, December 6, and the IPO allocation was confirmed on December 4. The BSE and NSE will list shares of Suraksha Diagnostic. Kfin Technologies is the IPO registrar and ICICI Securities, Nuvama Wealth Management, and SBI Capital Markets are the book running lead managers of the Suraksha Diagnostic IPO.

Suraksha Diagnostic: what should investors do?

1.27 subscriptions have been made to Suraksha Diagnostic Limited’s initial public offering. According to market expert Anil Singhvi, it is challenging to forecast when such undersubscribed shares will be listed. It is recommended that only high-risk investors make long-term investments in it; else, stay away. By setting a suitable stoploss at the bottom, short-term investors can make investments.

Stay connected with us for more such market trends and tips! 

(Disclaimer: Demat Dive is not giving any buying advice on any stock. Consult a SEBI registered advisor before investing anywhere.)


Authored by – Deepa Trivedi

Suraksha Diagnostic IPO

Shares

Suraksha Diagnostic IPO
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular